Patents by Inventor Gugliemo Palombini

Gugliemo Palombini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10507207
    Abstract: The invention refers to the use of Reverse Transcriptase (RT) inhibitor compounds for the preparation of pharmaceutical compositions to counteract the loss of cellular differentiation in tumour and non tumour pathologies, said compound being able to bind the hydrophobic pocket on the RT subunit p66. Particularly preferred for such uses are the following compounds: nevirapine, efavirenz, delavirdine, corresponding salts and/or pharmaceutically acceptable derivatives thereof.
    Type: Grant
    Filed: December 23, 2002
    Date of Patent: December 17, 2019
    Assignee: ISTITUTO SUPERIORE DI SANITA
    Inventors: Corrado Spadafora, Patriźia Ĺavia, Elisabetta Mattei, Gugliemo Palombini, Rodolfo Nello Lorenzini, Clara Nervi
  • Publication number: 20060166970
    Abstract: The invention refers to the use of Reverse Transcriptase (RT) inhibitor compounds for the preparation of pharmaceutical compositions to counteract the loss of cellular differentiation in tumour and non tumour pathologies, said compound being able to bind the hydrophobic pocket on the RT subunit p66. Particularly preferred for such uses are the following compounds: nevirapine, efavirenz, delavirdine, corresponding salts and/or pharmaceutically acceptable derivatives thereof.
    Type: Application
    Filed: December 23, 2002
    Publication date: July 27, 2006
    Inventors: Corrado Spadafora, Patrizia Lavia, Elisabetta Mattei, Gugliemo Palombini, Rodolfo Lorenzini, Clara Nervi